Dry Eye Syndrome Therapeutics Pipeline Assessment and Market Forecasts to 2017

Dry Eye Syndrome Therapeutics – Pipeline Assessment and Market Forecasts to 2017

Summary

GlobalData, the industry analysis specialist, has released its new report, “Dry Eye Syndrome Therapeutics – Pipeline Assessment and Market Forecasts to 2017”. The report is an essential source of information and analysis on the global dry eye syndrome market. The report identifies the key trends shaping and driving the global dry eye syndrome market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global dry eye syndrome sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

GlobalData forecasts the global dry eye syndrome therapeutics market to grow at 6.3% annually for the next seven years to reach $2.8 billion by 2017. It was valued at $1,858m in 2010. This significant growth is primarily attributed to increasing therapeutic options for the treatment of dry eye. In addition, the successful launch of some of the molecular targeted therapies, such as rebamipide and Remura (bromfenac) currently in NDA (New Drug Application) filing may significantly stimulate market growth in the near future. However, the low prescription rate and non-adherence to medication will continue to be a barrier for market growth.
GlobalData analyzed that the global Dry eye syndrome market is increasingly becoming more competitive. Balancing the pipeline with the current marketed products and expectations of patients and physicians, the pipeline is considered to be strong. The unmet need in Dry eye syndrome market is high and if a company wants to capture this unmet need, it will need to overcome the prevailing product weaknesses.

Scope

The scope of the report includes -
- Annualized global Dry eye syndrome market revenues data from 2005 to 2010, forecast forward for seven years to 2017.
- Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
- Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes anti inflammatory, mucin production enhancement agent, immunosuppressant, interleukin inhibitor, steroid hormone, receptor modulators, platelet aggregation inhibitor, mTOR inhibitor, metalloprotease inhibitor, NSAIDs, immune modulators, NGF mimetic and genesilencing.
- Analysis of the current and future market competition in the global Dry eye syndrome market. Key market players covered are Otsuka Pharmaceuticals, CanFite BioPharma, ISTA Pharmaceuticals, Pfizer and Alcon/Novartis.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with Dry eye syndrome

Reasons to buy

The report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Dry eye syndrome market.
- Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global Dry eye syndrome market in future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
- What’s the next big thing in the global Dry eye syndrome market landscape? – Identify, understand and capitalize